Shanghai Haohai Biological Technology Co. Ltd (5HB) — Cash Flow Quality Index

Latest as of June 2023: 1.38x

Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Cash Flow Quality Index of 1.38x as of June 2023. Operating cash flow of €141.99 Million exceeds net income of €102.62 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Haohai Biological Technology Co (5HB) cash conversion ratio to assess how effectively this company generates cash.

Cash Flow Quality Index

1.38x
Operating CF / Net Income

Operating Cash Flow

€141.99 Million
EUR

Net Income

€102.62 Million
EUR

Data as of

Jun 2023
Most recent filing

Shanghai Haohai Biological Technology Co. Ltd Cash Flow Quality Index (2016–2024)

Historical Cash Flow Quality Index for Shanghai Haohai Biological Technology Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shanghai Haohai Biological Technology Co total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Shanghai Haohai Biological Technology Co. Ltd (2016–2024)

Year-by-year earnings quality comparison for Shanghai Haohai Biological Technology Co. Ltd. For live market cap and the full company financial profile, see how much is Shanghai Haohai Biological Technology Co worth.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2024 1.54x €648.57 Million €420.45 Million ▲ +1.2%
2023 1.52x €634.45 Million €416.12 Million ▲ +19.0%
2022 1.28x €231.30 Million €180.47 Million ▲ +32.0%
2021 0.97x €342.29 Million €352.45 Million ▼ -14.7%
2020 1.14x €262.07 Million €230.07 Million ▲ +21.0%
2019 0.94x €348.91 Million €370.78 Million ▼ -0.3%
2018 0.94x €391.28 Million €414.54 Million ▲ +2.5%
2017 0.92x €343.06 Million €372.42 Million ▲ +10.4%
2016 0.83x €254.49 Million €305.05 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.